NEPHROCARE HEALTH SERV L (NEPHROPLUS) financials
NEPHROCARE HEALTH SERV L (NEPHROPLUS) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Incorporated in 2010, Nephrocare Health Services Ltd. provides end-to-end dialysis care through a wide network of clinics across India and select international markets.[1]
- Market Cap: ₹6,236Cr.
- Current Price: ₹620
- ROE: -1.38%
- ROCE: 5.65%
- Book Value: ₹96.8
- Dividend Yield: 0.00%
- 52W High / Low: ₹782/445
In Jun 2026, NEPHROCARE HEALTH SERV L (NEPHROPLUS) reported sales ₹170 Cr and net profit ₹13 Cr.
Annual TTM: sales ₹651 Cr, net profit ₹-1 Cr.
Shareholding: Promoters 63.85% (Jun 2026), FIIs 8.78% (Jun 2026), DIIs 9.05% (Jun 2026), Public 18.30% (Jun 2026), No. of Shareholders 44,091% (Jun 2026).
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 138 | 145 | 149 | 156 | 161 | 164 | 170 |
| Expenses | 116 | 123 | 129 | 132 | 138 | 142 | 146 |
| Operating Profit | 22 | 22 | 20 | 23 | 23 | 22 | 24 |
| OPM % | 16% | 15% | 13% | 15% | 14% | 13% | 14% |
| Other Income | 4 | 3 | 3 | 3 | 3 | 6 | 6 |
| Interest | 3 | 4 | 3 | 41 | 4 | 1 | 0 |
| Depreciation | 12 | 13 | 12 | 16 | 13 | 16 | 13 |
| Profit before tax | 11 | 7 | 7 | -31 | 9 | 11 | 17 |
| Tax % | 25% | 24% | 27% | 6% | 6% | 1% | 25% |
| Net Profit | 8 | 6 | 5 | -32 | 8 | 11 | 13 |
| EPS in Rs | 38.97 | 27.20 | 2.77 | -17.92 | 0.84 | 1.09 | 1.25 |
| Raw PDF | — | — | — | — | — | — | — |
| Category | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 284 | 317 | 386 | 436 | 544 | 630 | 651 |
| Expenses | 247 | 299 | 348 | 384 | 449 | 541 | 559 |
| Operating Profit | 38 | 18 | 38 | 52 | 95 | 89 | 93 |
| OPM % | 13% | 6% | 10% | 12% | 17% | 14% | 14% |
| Other Income | 5 | 4 | 5 | 8 | 16 | 15 | 19 |
| Interest | 7 | 10 | 15 | 17 | 14 | 50 | 47 |
| Depreciation | 34 | 39 | 41 | 43 | 51 | 58 | 58 |
| Profit before tax | 1 | -28 | -13 | 0 | 45 | -4 | 6 |
| Tax % | 22% | -22% | 20% | -1,668% | 25% | 114% | — |
| Net Profit | 1 | -22 | -15 | 4 | 34 | -8 | -1 |
| EPS in Rs | 5.57 | -110.19 | -77.01 | 18.76 | 164.24 | -0.80 | -14.74 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | — |
| Category | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 2 | 2 | 20 |
| Reserves | 246 | 407 | 392 | 399 | 540 | 951 |
| Borrowings | 140 | 119 | 200 | 182 | 133 | 12 |
| Other Liabilities | 32 | 45 | 54 | 82 | 81 | 152 |
| Total Liabilities | 419 | 572 | 647 | 665 | 757 | 1,135 |
| Fixed Assets | 159 | 167 | 169 | 219 | 234 | 245 |
| CWIP | 0 | 2 | 3 | 1 | 4 | 4 |
| Investments | 47 | 110 | 148 | 149 | 212 | 335 |
| Other Assets | 212 | 293 | 328 | 297 | 306 | 551 |
| Total Assets | 419 | 572 | 647 | 665 | 757 | 1,135 |
| Category | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from Operating Activity | 33 | 12 | 11 | 57 | 80 | 133 |
| Cash from Investing Activity | -64 | -167 | -75 | -23 | -104 | -299 |
| Cash from Financing Activity | 36 | 147 | 63 | -36 | 26 | 256 |
| Net Cash Flow | 4 | -8 | -0 | -1 | 2 | 90 |
| Free Cash Flow | -18 | -31 | -28 | -18 | -1 | 57 |
| CFO/OP | 51% | 93% | 19% | 120% | 80% | 169% |
| Category | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Promoters | 63.85% | 63.85% | 63.85% |
| FIIs | 9.30% | 9.94% | 8.78% |
| DIIs | 8.10% | 8.64% | 9.05% |
| Public | 18.74% | 17.56% | 18.30% |
| No. of Shareholders | 67,416 | 43,409 | 44,091 |
| Category | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor Days | 98 | 106 | 122 | 116 | 130 | 126 |
| Inventory Days | 65 | 50 | 61 | 51 | — | — |
| Days Payable | 56 | 52 | 40 | 108 | — | — |
| Cash Conversion Cycle | 107 | 104 | 143 | 59 | 130 | 126 |
| Working Capital Days | 21 | 48 | 116 | 58 | 62 | 56 |
| ROCE % | — | -4% | 0% | 3% | 9% | 6% |
Nephrocare Health Serv L
₹6,236Cr.
₹620
₹782/445
Incorporated in 2010, Nephrocare Health Services Ltd. provides end-to-end dialysis care through a wide network of clinics across India and select international markets.[1]
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of NEPHROCARE HEALTH SERV L (NEPHROPLUS)?
The reported market capitalisation for NEPHROCARE HEALTH SERV L (NEPHROPLUS) is ₹6,236Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of NEPHROPLUS?
The current price shown for NEPHROCARE HEALTH SERV L (NEPHROPLUS) on Fincrux is ₹620 with a 52-week high/low of ₹782/445.
What were NEPHROPLUS latest quarterly results?
For Jun 2026, NEPHROCARE HEALTH SERV L (NEPHROPLUS) reported sales ₹170 Cr and net profit ₹13 Cr (figures in ₹ crore unless noted).
What are NEPHROPLUS annual sales and net profit?
For TTM, NEPHROCARE HEALTH SERV L (NEPHROPLUS) shows sales of ₹651 Cr and net profit of ₹-1 Cr on the Fincrux profit & loss statement.
Who owns NEPHROCARE HEALTH SERV L (NEPHROPLUS)?
Latest shareholding for NEPHROCARE HEALTH SERV L (NEPHROPLUS) on Fincrux: Promoters 63.85% (Jun 2026), FIIs 8.78% (Jun 2026), DIIs 9.05% (Jun 2026), Public 18.30% (Jun 2026), No. of Shareholders 44,091% (Jun 2026).
Where can I find NEPHROCARE HEALTH SERV L (NEPHROPLUS) financials?
NEPHROCARE HEALTH SERV L (NEPHROPLUS) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show NEPHROPLUS balance sheet and cash flow?
Yes. The NEPHROCARE HEALTH SERV L (NEPHROPLUS) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.